No Data
No Data
Newron Pharmaceuticals Nominates Former ADC Therapeutics CEO for Chairmanship
Earnings Preview: ADCT to Report Financial Results Pre-market on March 27
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
ADC Therapeutics SA (NYSE:ADCT) Held Back By Insufficient Growth Even After Shares Climb 26%
ADC THERAPEUTICS SA -REDH Earnings Preview: Recent $ADCT Insider Trading, Hedge Fund Activity, and More
Express News | Cantor Fitzgerald Reiterates Overweight on ADC Therapeuticsto Overweight